Monoclonal antibody targeting chikungunya virus envelope 1 protein inhibits virus release
Chikungunya virus (CHIKV) causes an acute clinical illness characterized by sudden high fever, intense joint pain, and skin rash. Recent outbreaks of chikungunya disease in Africa and Asia are a major public health concern; however, there is currently no effective licensed vaccine or specific treatm...
Saved in:
Main Authors: | Promsin Masrinoul, Orapim Puiprom, Atsushi Tanaka, Miwa Kuwahara, Panjaporn Chaichana, Kazuyoshi Ikuta, Pongrama Ramasoota, Tamaki Okabayashi |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/34017 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Characterization of chikungunya virus infection of a human keratinocyte cell line: Role of mosquito salivary gland protein in suppressing the host immune response
by: Orapim Puiprom, et al.
Published: (2018) -
Chikungunya virus was isolated in Thailand, 2010
by: Mikiko Sasayama, et al.
Published: (2018) -
Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients
by: Panjaporn Chaichana, et al.
Published: (2018) -
Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus
by: Chonlatip Pipattanaboon, et al.
Published: (2018) -
Limited cross-reactivity of mouse monoclonal antibodies against Dengue virus capsid protein among four serotypes
by: Megumi Noda, et al.
Published: (2018)